ENTRY       D10522                      Drug
NAME        Eftrenonacog alfa (INN);
            Eftrenonacog alfa (genetical recombination) (JAN);
            Alprolix (TN)
FORMULA     C4330H6648N1164O1331S41
EXACT_MASS  97559.6852
MOL_WEIGHT  97620.7813
SEQUENCE    (A chain)
            YNSGKLEEFV QGNLERECME EKCSFEEARE VFENTERTTE FWKQYVDGDQ CESNPCLNGG
            SCKDDINSYE CWCPFGFEGK NCELDVTCNI KNGRCEQFCK NSADNKVVCS CTEGYRLAEN
            QKSCEPAVPF PCGRVSVSQT SKLTRAETVF PDVDYVNSTE AETILDNITQ STQSFNDFTR
            VVGGEDAKPG QFPWQVVLNG KVDAFCGGSI VNEKWIVTAA HCVETGVKIT VVAGEHNIEE
            TEHTEQKRNV IRIIPHHNYN AAINKYNHDI ALLELDEPLV LNSYVTPICI ADKEYTNIFL
            KFGSGYVSGW GRVFHKGRSA LVLQYLRVPL VDRATCLRST KFTIYNNMFC AGFHEGGRDS
            CQGDSGGPHV TEVEGTSFLT GIISWGEECA MKGKYGIYTK VSRYVNWIKE KTKLTDKTHT
            CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH
            NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE
            PQVYTLPPSR DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF
            LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (B chain)
            DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD
            GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
            GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
            DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Disulfide bridge: A18-23, A51-62, A55-71, A73-82, A88-99, A95-109, A111-124, A132-289, A206-222, A336-350, A361-389, A421-B6, A424-B9, A456-516, B41-101, B147-205)
  TYPE      Peptide
CLASS       Blood modifier agent
             DG02016  Hemostatics
              DG02014  Blood coagulation accelerant
               DG02013  Blood coagulation factor
REMARK      Therapeutic category: 6349
            ATC code: B02BD04
            Product: D10522<JP>
EFFICACY    Bleeding suppressant, Replenisher (coagulation factor)
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BD Blood coagulation factors
                 B02BD04 Coagulation factor IX
                  D10522  Eftrenonacog alfa (INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               634  Human blood preparations
                6349  Others
                 D10522  Eftrenonacog alfa (INN); Eftrenonacog alfa (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG02016  Hemostatics
               DG02014  Blood coagulation accelerant
                DG02013  Blood coagulation factor
                 D10522  Eftrenonacog alfa
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10522
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10522
DBLINKS     CAS: 1270012-74-2
            PubChem: 254741484
///
